New research from the University of California, Irvine reveals how the circadian regulation of glucose production in the liver is…
Home »
Pralsetinib Promising New Agent for RET Fusion-Protein-Positive Lung Cancer
NEW YORK (Reuters Health) – Oral pralsetinib elicits strong antitumor activity in patients with advanced or metastatic non-small-cell lung cancer…
Nearly 4 in 10 Cancer Deaths Attributable to Cigarette Smoking
Although rates of smoking have been declining in the United States, smoking is still contributing substantially to the cancer burden,…
Pemetrexed Apotex
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEMETREXED APOTEX POWDER FOR INJECTION Contains the…
Researchers characterize lung inflammation associated with some cancer immnunotherapy: Findings might help predict who will react poorly to certain therapies
Immune checkpoint inhibitors are a type of therapy that uses the immune system to fight cancer. They have been hailed…
Little-used drug combination may extend the lives of lung transplant patients
Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant…
Scientists discover the basics of how pressure-sensing Piezo proteins work
A team of scientists from Weill Cornell Medicine and The Rockefeller University has illuminated the basic mechanism of Piezo proteins,…
‘Kissing loops’ in RNA molecule essential for its role in tumor suppression
Human cells — like those of many other organisms — have developed mechanisms to protect us from cancer. Healthy cells…
Lung cancer symptoms: Seven signs your cough could be signalling the deadly condition
Lung cancer symptoms usually don’t show in the early stages, but with this type of cancer being one of the…
Bringing cancer medication safely to its destination
Treating cancer more selectively and more effectively — this could be achieved with an innovative technology developed by teams of…